Integrated list of glycoproteins extracted from UniProt and annotated with glycosylation data from GlyGen, GlyConnect, GlycoProtDB and The O-GlcNAc Database. For each entry, information such as glycosylation site, glycans, diseases, 3D structures, and pathway information are available.
Source | Last Updated |
---|---|
GlyConnect | April 19, 2023 |
GlycoProtDB | October 1, 2021 |
GlyGen | June 4, 2024 |
The O-GlcNAc Database | June 3, 2024 |
UniProt | June 4, 2024 |
UniProt ID ▼ | Protein Name | Gene Symbol | Organism | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|---|
Q32NG4 | Glutamine amidotransferase-like class 1 domain-containing protein 1 |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q2VQV9 | Adenosine deaminase 2 |
|
Xenopus laevis (African clawed frog) | 4 | 0 |
|
Q2TAD5 | Apelin receptor B |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q202B1 | Protein ATP1B4 |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q1EQW0 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
Xenopus laevis (African clawed frog) | 1 | 0 |
|
Q1AGV7 | Syndecan 4-A |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
Q1AGV6 | Syndecan 4-B |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
Q10835 | Collagenase 3 (Fragment) |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q0VGW6 | Solute carrier family 12 member 9 |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q0VGW4 | Endoplasmic reticulum metallopeptidase 1 |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
Q0IHJ2 | Arylsulfatase K |
|
Xenopus laevis (African clawed frog) | 5 | 0 |
|
Q0IHI1 | Thioredoxin domain-containing protein 15 |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
Q0IHF1 | Transmembrane protein 39A-A |
|
Xenopus laevis (African clawed frog) | 4 | 0 |
|
Q0IHD4 | Potassium channel subfamily K member |
|
Xenopus laevis (African clawed frog) | 1 | 0 |
|
Q0IH22 | Blood vessel epicardial substance-B |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q09062 | Integrin beta-2 (Fragment) |
|
Xenopus laevis (African clawed frog) | 1 | 0 |
|
Q08B63 | Lysyl oxidase homolog 2 |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
Q06PM8 | Glial cell line-derived neurotrophic factor |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q06441 | Thrombospondin-4 |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q06274 | Integrin alpha-5 |
|
Xenopus laevis (African clawed frog) | 15 | 0 |
|
Q03364 | Fibroblast growth factor receptor 2 |
|
Xenopus laevis (African clawed frog) | 7 | 0 |
|
Q00387 | Serine protease inhibitor A6 |
|
Xenopus laevis (African clawed frog) | 2 | 0 |
|
Q00223 | Putative gastrointestinal growth factor xP4 |
|
Xenopus laevis (African clawed frog) | 1 | 0 |
|
P98999 | Adenylate cyclase type 9 |
|
Xenopus laevis (African clawed frog) | 3 | 0 |
|
P98070 | Bone morphogenetic protein 1 |
|
Xenopus laevis (African clawed frog) | 5 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024